Evidence map›Paper›PMID 29712666›Full record

Trial reportBlood advances2018

Randomized phase 2 trial of monthly vitamin D to prevent respiratory complications in children with sickle cell disease.

Margaret T Lee, Meyer Kattan, Ilene Fennoy, Stephen M Arpadi, Rachel L Miller, Serge Cremers, Donald J McMahon, Jeri W Nieves, Gary M Brittenham

Registry-linked trialOpen access · goldAbstract readClinical Trial, Phase IIRandomized Controlled Trial
In one paragraph

Trial report in Blood advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04170348 (Daily Vitamin D for Sickle-cell Respiratory Complications), which is not on this map. Cited by 22 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 6 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04170348 phase2completednot on this mapstarted 2020, after this paper: background citation

Daily Vitamin D for Sickle-cell Respiratory Complications

TypeinterventionalSponsorColumbia UniversityRan2020 to 2024Enrolled58ConditionsSickle Cell Disease, Anemia, Sickle Cell, Anemia, Hemolytic, Congenital, Respiratory Tract DiseasesArmsDaily oral vitamin D3, 3,333 IU, Monthly oral vitamin D3, 100,000 IU, Placebo oral tablet
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 6 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Vitamin D for the management of asthma.The Cochrane database of systematic reviews · 2023
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Vitamin D supplementation for sickle cell disease.The Cochrane database of systematic reviews · 2020
    Pooled it
  7. Safety and efficacy of monthly high-dose vitamin DEuropean journal of pediatrics · 2024
    Trial
  8. Trial
  9. Vitamin D Supplementation Improves Health-Related Quality of Life and Physical Performance in Children with Sickle Cell Disease and in Healthy Children.Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners
    Trial
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Margaret T LeeDivision of Pediatric Hematology/Oncology/Stem Cell Transplantation.
Meyer KattanDivision of Pediatric Pulmonology.
Ilene FennoyDivision of Pediatric Endocrinology, and.
Stephen M ArpadiDivision of Child and Adolescent Health, Department of Pediatrics, Columbia University Medical Center, New York, NY.
Rachel L MillerDivision of Pediatric Allergy, Immunology and Rheumatology, Department of Pediatrics.
Serge CremersDivision of Endocrinology, Department of Medicine, Columbia University Medical Center, New York, NY.
Donald J McMahonDivision of Endocrinology, Department of Medicine, Columbia University Medical Center, New York, NY.
Jeri W NievesDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY; and.
Gary M BrittenhamDivision of Pediatric Hematology/Oncology/Stem Cell Transplantation.
Columbia University Irving Medical Center · USColumbia University · USPulmonary and Allergy Associates · USPulmonary Associates · US

Funding

Clinical and Translational Science AwardUL1TR000040 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2012 to 2015
$26.2M
Ph 2 Study of Vitamin D for Tx of Respiratory Complications in Sickle Cell DsR01FD003894 · FDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BRITTENHAM, GARY M, LEE, MARGARET T · 2011 to 2014
$1.6M
FDA HHS R01 FD003894NCATS NIH HHS UL1 TR000040
6 · The paper itself

Abstract

In sickle cell disease, respiratory infection and asthma may lead to respiratory complications that are a leading cause of morbidity and mortality. Vitamin D has anti-infective and immunomodulatory effects that may decrease the risk for respiratory infections, asthma, and acute chest syndrome. We conducted a randomized double-blind active-controlled clinical trial to determine whether monthly oral vitamin D

Indexed as

Acute Chest SyndromeAdolescentAsthmaChildCholecalciferolDouble-Blind MethodFemaleHumansMaleRespiratory Tract InfectionsTime FactorsCholecalciferol

Identifiers

PMID29712666
PMCPMC5941998
OpenAlexW2801790576

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.